Oxyurea capsules 100mg by 30

Oxyurea Capsules 100mg – Pack of 30 Product Description Oxyurea 100mg Capsules contain Hydroxyurea, an oral cytotoxic agent used in the treatment of chronic myeloid leukemia (CML), sickle cell anemia, and certain solid tumors. It works by inhibiting DNA synthesis in rapidly dividing cells, helping to control abnormal cell growth and reduce disease-related complications. Each capsule delivers 100mg of Hydroxyurea, and this 30-capsule pack is typically used for daily or alternate-day dosing depending on the condition being managed. Key Features

Contains Hydroxyurea 100mg per capsule Used in treatment of leukemia, myeloproliferative disorders, and sickle cell disease Oral chemotherapy agent – convenient for outpatient use Helps reduce frequency of sickle cell crises Slows progression of blood cancers and abnormal cell growth

Indications

Chronic myeloid leukemia (CML) Essential thrombocythemia Polycythemia vera Sickle cell disease (to reduce painful crises and need for transfusions) Certain solid tumors (as part of combination chemotherapy)

Directions for Use

Take as prescribed by a specialist or oncologist. Dosage depends on the condition, weight, and blood counts. Swallow capsules whole with water; do not open or crush. Regular blood tests are required to monitor therapy.

Precautions

Prescription-only medication; use under strict medical supervision Cytotoxic – handle with care; avoid contact with broken capsules Not recommended during pregnancy or breastfeeding Can cause bone marrow suppression, requiring close monitoring May interact with other chemotherapy or immunosuppressive agents

Possible Side Effects

Bone marrow suppression (anemia, low white cells or platelets) Nausea, vomiting, loss of appetite Skin or nail darkening, hair thinning Rare: mouth ulcers, liver function changes

Important Information Oxyurea Capsules are a high-risk medicine intended for use in cancer or hematology patients under medical guidance. Regular monitoring and adherence to dosing schedules are essential. Patients should avoid self-adjusting the dose or stopping treatment without consulting their healthcare provider.